International Journal of Cardiology
Volume 135, Issue 3 , Pages 376-384 , 10 July 2009

Stent implantation in patients with severe left ventricular systolic dysfunction

  • Carlo Briguori

      Affiliations

    • Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy
    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • ,
  • Tiziana Claudia Aranzulla

      Affiliations

    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • ,
  • Flavio Airoldi

      Affiliations

    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • ,
  • John Cosgrave

      Affiliations

    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • ,
  • Davide Tavano

      Affiliations

    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • ,
  • Iassen Michev

      Affiliations

    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • ,
  • Matteo Montorfano

      Affiliations

    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • ,
  • Mauro Carlino

      Affiliations

    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • ,
  • Alfredo Castelli

      Affiliations

    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • ,
  • Massimo Giuseppe Sangiorgi

      Affiliations

    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • ,
  • Antonio Colombo

      Affiliations

    • Laboratory of Interventional Cardiology, “Vita e Salute” University School of Medicine, San Raffaele Hospital, Milan, Italy
    • Corresponding Author InformationCorresponding author. Interventional Cardiology San Raffaele Hospital Via Olgettina, 60 20145 Milan, Italy. Tel.: +39 02 26437418; fax: +39 02 26432339.

Received 10 December 2007 ,Revised 1 April 2008 ,Accepted 4 April 2008.

References 

  1. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331–336
  2. Emond M, Mock MB, Davis KB, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645–2657
  3. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular dysfunction (CASS). Circulation. 1983;68:785–795
  4. Passamani E, Davis KB, Gillespier MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with low ejection fraction. N Engl J Med. 1985;312:1665–1671
  5. Topkara VK, Cheema FH, Kesavaramaujam S, et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005;112:344–350
  6. Christakis GT, Weisel RD, Fremes SE, et al. Coronary artery bypass grafting in patients with poor left ventricular function. Cardiovascular surgeons of the University of Toronto. J Thorac Cardiovasc Surg. 1992;103:1083–1091
  7. Sedlis SP, Ramanathan KB, Morrison DA, Sethi G, Sacks J, Henderson W. Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry). Am J Cardiol. 2004;94:118–120
  8. Keelan PC, Johnston JM, Koru-Sengul T, et al. Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions ≤ 40%, 41% to 49%, and ≥ 50% having percutaneous coronary revascularization. Am J Cardiol. 2003;91:1168–1172
  9. Stevens T, Kahn JK, McCallister BD, et al. Safey and efficacy of percutaneous coronary angioplasty in patients with left ventricular dysfunction. Am J Cardiol. 1991;68:313–319
  10. Briguori C, Sarais C, Pagnotta P, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J. 2003;145:700–707
  11. Serota H, Deligonul U, Lee W-H, et al. Predictors of cardiac survival after percutaneous transluminal coronary angioplasty in patients with severe left ventricular dysfunction. Am J Cardiol. 1991;67:367–372
  12. Eltchaninoff H, Franco I, Whitlow P. Late results of coronary angioplasty in patients with left ventricular ejection fractions < 40%. Am J Cardiol. 1994;73:1047–1052
  13. Di Sciascio G, Patti G, D'Ambrosio A, Nusca A. Coronary stenting in patients with depressed left ventricular function. Catheter Cardiovasc Interv. 2003;59:429–433
  14. Hannan EL, Racz M, Holmes DR, et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006;113:2406–2412
  15. Reiber J, Serruys P. Progress in quantitative coronary arteriography. Dordrecht. The Netherlands: Kluwer; 1994;
  16. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502–1513
  17. Guidelines for percutaneous coronary interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Authors/Task Force Members. Eur Heart J. 2005;26:804–847
  18. Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856–1864
  19. Maiello L, Colombo A, Gianrossi R, Almagor Y, Finci L. Survival after percutaneous transluminal coronary angioplasty in patients with severe left ventricular dysfunction. Chest. 1994;105:733–740
  20. Stevens T, Kahn JK, McCallister BD, et al. Safety and efficacy of percutaneous transluminal coronary angioplasty in patients with left ventricular dysfunction. Am J Cardiol. 1991;68:313–339
  21. Alderman E, Bourassa M, Cohen L for the CASS Investigators. Ten year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;85:1629–1646
  22. Bounous E, Mark D, Pollock B, et al. Surgical survival benefit for coronary disease patients with left ventricular dysfunction. Circulation. 1988;78:151–157
  23. Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337:1569–1575
  24. Buxton AE, Moss AJ. Should everyone with an ejection fraction less than or equal to 30% receive and implantable cardioverter-defibrillator?. Circulation. 2005;111:2537–2549
  25. Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2000;101:558–569
  26. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1–82
  27. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933–1940
  28. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882–1890
  29. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  30. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol. 2002;40:1703–1719
  31. Veenhuyzen GD, Singh SN, McAreavey D, Shelton BJ, Exner DV. Prior coronary artert bypass surgery and risk of death among patients with ischemic left ventricular dysfunction. Circulation. 2001;104:1489–1493
  32. Bourassa MG, Kip KE, Jacobs AK, et al. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 1999;33:1627–1636
  33. van den Brand MJ, Rensing BJ, Morel MA, et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. 2002;39:559–564
  34. Kleisli T, Cheng W, Jacobs MJ, et al. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2005;129:1283–1291
  35. O' Keefe JH, Allan JJ, McCallister BD, et al. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction ≤ 40%. Am J Cardiol. 1993;7:897–901

PII: S0167-5273(08)00589-5

doi: 10.1016/j.ijcard.2008.04.013

International Journal of Cardiology
Volume 135, Issue 3 , Pages 376-384 , 10 July 2009

Article Tools

* Image Usage & Resolution